Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T

[1] Hahn PF(1990)First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging Radiology 175 695-700

[2] Stark DD(1987)Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system Radiology 162 211-216

[3] Lewis JM(1994)Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227 Magn Reson Imaging 12 1161-1165

[4] Saini S(1993)Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI Magn Reson Imaging 11 1139-1145

[5] Elizondo G(1995)Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196 481-488

[6] Weissleder R(1998)Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs Magn Reson Imaging 16 755-763

[7] Fretz CJ(1999)Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography J Magn Reson Imaging 9 220-227

[8] Ferrucci JT(2012)Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients With Acute Myocardial Infarction: Early Clinical Experience Circ Cardiovasc Imaging 5 559-565

[9] Saini S(2013)Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach Eur Heart J 34 462-475

[10] Stark DD(2011)Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide: A Pilot Study Circ Cardiovasc Imaging 4 274-281

[1] Hahn PF(1990)First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging Radiology 175 695-700

[2] Stark DD(1987)Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system Radiology 162 211-216

[3] Lewis JM(1994)Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227 Magn Reson Imaging 12 1161-1165

[4] Saini S(1993)Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI Magn Reson Imaging 11 1139-1145

[5] Elizondo G(1995)Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196 481-488

[6] Weissleder R(1998)Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs Magn Reson Imaging 16 755-763

[7] Fretz CJ(1999)Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography J Magn Reson Imaging 9 220-227

[8] Ferrucci JT(2012)Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients With Acute Myocardial Infarction: Early Clinical Experience Circ Cardiovasc Imaging 5 559-565

[9] Saini S(2013)Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach Eur Heart J 34 462-475

[10] Stark DD(2011)Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide: A Pilot Study Circ Cardiovasc Imaging 4 274-281